Washington, Jan 17 (AP) Popular weight-loss drugs such as Ozempic and Wegovy have been added to Medicare's list of medications that will be negotiated directly between the US government and drug manufacturers, the Joe Biden administration said Friday.

The price negotiations for the additional 15 drugs selected will be handled by the incoming Donald Trump administration and almost assures billions of dollars in savings for the taxpayers.

Also Read | Death of Indian National in Russia: 12 Indians Serving in Russian Army Killed in Ukraine, India Seeking ‘Early Return of Those Who Remain’.

In addition to Ozempic and Wegovy, some of the other medications include Trelegy Ellipta, which treats asthma; Otezla, a psoriatic arthritis drug; and several that treat different forms of cancer.

The list is a first step in negotiations and, given the timing, the details and final pricing will be left to President-elect Donald Trump's administration.

Also Read | Israel-Hamas Ceasefire Deal: Benjamin Netanyahu Led-Security Cabinet Recommends Approval of Ceasefire in Gaza; Deal Goes to Full Cabinet.

"For some people, this is a big deal," US health and human services secretary Xavier Becerra said in a call with reporters on Thursday.

"Some folks have to skip a dose in their prescription so they can make a prescription last longer."

That brings the total to 25 drugs that will have lower price tags under a historic new programme which allows the government to haggle over the price Medicare pays on the most popular and expensive drug scripts filled by older Americans.

Those 25 drugs account for a third of Medicare spending on prescriptions, Becerra said. (AP)

(This is an unedited and auto-generated story from Syndicated News feed, LatestLY Staff may not have modified or edited the content body)